Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Impact BioMedical, Inc. (IBO)
NYSE MKT:IBO
Holding IBO?
Track your performance easily
IBO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.22 - $3.25
Previous Close$2.51
Volume53.76K
Average Volume (3M)102.61K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$2.67M
Total Debt (Recent Filing)$8.01M
Price to Earnings (P/E)28.1
Beta-2.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding11,503,955
10 Day Avg. Volume80,583
30 Day Avg. Volume102,607
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.92
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.30% Mutual Funds
― Other Institutional Investors
99.69% Public Companies and
Individual Investors
IBO FAQ
What was Impact BioMedical, Inc.’s price range in the past 12 months?
Impact BioMedical, Inc. lowest stock price was $1.22 and its highest was $3.25 in the past 12 months.
What is Impact BioMedical, Inc.’s market cap?
Currently, no data Available
When is Impact BioMedical, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Impact BioMedical, Inc.’s earnings last quarter?
Currently, no data Available
Is Impact BioMedical, Inc. overvalued?
According to Wall Street analysts Impact BioMedical, Inc.’s price is currently Overvalued.
Does Impact BioMedical, Inc. pay dividends?
Impact BioMedical, Inc. does not currently pay dividends.
What is Impact BioMedical, Inc.’s EPS estimate?
Impact BioMedical, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Impact BioMedical, Inc. have?
Impact BioMedical, Inc. has 11,503,955 shares outstanding.
What happened to Impact BioMedical, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Impact BioMedical, Inc.?
Currently, no hedge funds are holding shares in IBO
---
Impact BioMedical, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
4.01%
Trailing 12-Months
Asset Growth
3.58%
Trailing 12-Months
Company Description
Impact BioMedical, Inc.
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, it develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications.
---
Technical Analysis
---